<DOC>
	<DOC>NCT01984320</DOC>
	<brief_summary>The effectiveness of cabergoline to prevent moderate-severe OHSS to coasting.</brief_summary>
	<brief_title>Cabergoline and Coasting to Prevent OHSS</brief_title>
	<detailed_description>To randomly compare three study groups under a high risk of developing OHSS to one of three arms of management, either coasting for 1 to 3 days or receiving cabergoline for 8 days or coasting for 1 day plus receiving cabergoline for 8 days in ICSI patients following the long luteal GnRH agonist protocol.</detailed_description>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Cabergoline</mesh_term>
	<mesh_term>Menotropins</mesh_term>
	<criteria>1. Age &lt;or= 35, BMI &lt;or= 30 2. Long protocol GnRH agonist cycles 3. Estradiol level on day of HCG &gt;or= 3500 pg/ml 4. Retrieving more than 15 oocytes 1. Male factor 2. Uterine factor</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>OHSS</keyword>
	<keyword>ICSI</keyword>
	<keyword>Coasting</keyword>
	<keyword>Cabergoline</keyword>
</DOC>